Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-15T18:31:48.677Z Has data issue: false hasContentIssue false

The validity of observer-based scales in the measure of drug-induced motor symptoms in a spanish sample of patients with severe mental disorders

Published online by Cambridge University Press:  23 March 2020

J. Aznarte*
Affiliation:
Servicio Andaluz de Salud, Psiquiatria, Linares, Spain
Y. Crespo
Affiliation:
Universidad de Jaén, PhD Biology, Jaén, Spain
S. Iglesias-Parro
Affiliation:
Universidad de Jaén, Psychology, Jaén, Spain
M.F. Soriano-Peña
Affiliation:
Servicio Andaluz de Salud, Mental Health, Linares, Spain
A. Ibáñez Molina
Affiliation:
Universidad de Jaén, Psychology, Jaén, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

Antipsychotic drugs are effective in schizophrenic disorders, but they are also used to treat other psychiatric conditions. Typical antipsychotics cause important extrapyramidal symptoms (EPS), which frequently result in non-compliance with antipsychotic medication. It has been stated that the second-generation antipsychotics (atypical) provoke EPS side effects less frequently than typical antipsychotics. However, there is some controversy around this statement, especially because of inefficient measures of EPS. Clinical assess of EPS normally relies upon observer-based ratings, but their reliability and validity has not been consistently established.

Objective

In the present work, we have explored the convergent and discriminant validity of the Abnormal Involuntary Movement Scale (AIMS) and the Simpson-Angus Scale (SEE), in a Spanish sample of patients with severe mental disorders. Patients could be under typical or atypical antipsychotics, antidepressants, benzodiacepines, or a combination of these.

Method

Sixty-one patients with severe mental disorders from the Mental Health Day Hospital of St. Agustín (Linares, Spain) participated in the study. Inclusion criteria were DSM-V diagnosis of schizophrenia or schizophrenic disorder, bipolar, or borderline personality disorders, and age between 18-61. In order to explore the discrimination capacity of each rating scale, Receiver Operator Characteristic (ROC) analyses were conducted.

Results

ROC curves indicated a suitable construct validity of the scales in the measurement of drug-induced motor symptoms. However, the scales were not sensitive to the number of years under treatment.

Conclusions

In line with previous research, our results question the use of rating scales as the only measure in the evaluation of EPS symptoms.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EW491
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.